1-8 of 8
p14arf protein
Close
Sort by
Journal Articles

hnRNP K: A Putative Regulator of Leukemogenesis and the p53 Pathway

Alfonso Quintas-Cardama, MD, Xiaorui Zhang, Youmna Attieh, Hun Ju Lee, MD, Yi Hua Qiu, MD, Steven M. Kornblau, MD, PhD, Sean Post
Journal: Blood
Blood (2012) 120 (21): 774.
https://doi.org/10.1182/blood.V120.21.774.774
Published: 2012
Journal Articles

Plasma Cell Leukemia.

Rafael Fonseca, MD
Journal: Blood
Blood (2009) 114 (22): SCI-4.
https://doi.org/10.1182/blood.V114.22.SCI-4.SCI-4
Published: 2009
Journal Articles

Role of Nucleophosmin Mutations in AML.

Kotaro Funato, MD, PhD, David W. Sternberg, MD, PhD
Journal: Blood
Blood (2008) 112 (11): sci-13.
https://doi.org/10.1182/blood.V112.11.sci-13.sci-13
Published: 2008
Journal Articles

Delta Ex6, the Novel Transactivation-Defective Splicing Variant of p53 Gene, Is Differentially Expressed in Patients with Chronic Lymphocytic Leukemia and Confers Accented Proliferative Phenotype in Vitro

Sona Pekova, M.D., PhD., Radek Cmejla, PhD, Tomas Kozak, MD, PhD, Lukas Smolej, MD, PhD, Martin Spacek, MD., Miroslav Prucha, MD., PhD., Ondrej Hrusak
Journal: Blood
Blood (2008) 112 (11): 3795.
https://doi.org/10.1182/blood.V112.11.3795.3795
Published: 2008
Journal Articles

Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival.

Esbjorn O. Paul, MD, Stefan Deneberg, MD, Soren Lehmann, MD, PhD, Sofia BengtzeĢn, Ms., Hareth Nahi, MD, PhD.
Journal: Blood
Blood (2007) 110 (11): 4261.
https://doi.org/10.1182/blood.V110.11.4261.4261
Published: 2007
Journal Articles

Promoter Methylation of Multiple Genes in Diffuse Large Cell Lymphoma (DLCL), Follicular Lymphoma (FL) and Bening Follicular Hyperplasia (BFH).

Jose M. Paz-Carreira, MD, Raquel Losada, Ph.D., Arantxa Garcia-Rivero, Ph.D., Augusto Alvarez, M.D., Fernando Bal, M.D., Guillermo Deben, M.D., Jesus Alba-Losada, M.D.
Journal: Blood
Blood (2007) 110 (11): 2608.
https://doi.org/10.1182/blood.V110.11.2608.2608
Published: 2007
Journal Articles

Targeting Mutant Nucleophosmin (NPM)1: A Promising Approach To Induce Growth Inhibition and Differentiation in Human AML.

Bryan Herger, PhD, Warren Fiskus, Ph.D., Rekha Rao, Ph.D., Kapil Bhalla, M.D.
Journal: Blood
Blood (2006) 108 (11): 1905.
https://doi.org/10.1182/blood.V108.11.1905.1905
Published: 2006
Journal Articles

The Histone Deacetylase Inhibitor (HDI) Depsipeptide Has Differential Activity in Core Binding Factor AML.

Olatoyosi M. Odenike, Serhan Alkan, Dorie Sher, John E. Godwin, Dezheng Huo, Stephen J. Brandt, Jingping Xie, Yanming Zhang, David H. Vesole, Richard A. Larson, Wendy Stock
Journal: Blood
Blood (2006) 108 (11): 1956.
https://doi.org/10.1182/blood.V108.11.1956.1956
Published: 2006